GHAPP_site_logo-white.png
Sign up for Updates
  • Facebook - White Circle
  • Twitter - White Circle
  • Instagram - White Circle
  • LinkedIn - White Circle

© 2019 Gastroenterology & Hepatology Advanced Practice Providers

Drug Induced Liver Toxicity

Target Audience

This activity has been designed to meet the educational needs of gastroenterologists, nurse practitioners and physician assistants.

Educational Objectives

At the conclusion of this activity, participants will be able to:

    • Review the clinical manifestations and classifications of drug-induced liver toxicity
    • Discuss treatment and management of drug-induced liver toxicity

Accreditation Statement

This activity has been planned and implemented in accordance with the accreditation requirements and policies of the Accreditation Council for Continuing Medical Education through the joint providership of the Annenberg Center for Health Sciences at Eisenhower and the Chronic Liver Disease Foundation (CLDF). The Annenberg Center for Health Sciences at Eisenhower is accredited by the ACCME to provide continuing medical education for physicians.

The Annenberg Center for Health Sciences at Eisenhower designates this live activity for a maximum of 0.5 AMA PRA Category 1 Credits™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

Nurse Practitioner Statement

This activity has been planned and implemented in accordance with the accreditation requirements and policies of the Accreditation Council for Continuing Medical Education through the joint providership of the Annenberg Center for Health Sciences at Eisenhower and the Chronic Liver Disease Foundation (CLDF). The Annenberg Center for Health Sciences at Eisenhower is accredited by the ACCME to provide continuing medical education for physicians.

The Annenberg Center for Health Sciences at Eisenhower designates this live activity for a maximum of 0.5 AMA PRA Category 1 Credits™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

Disclosure of Conflicts of Interest

All faculty and staff involved in the planning or presentation of continuing education activities provided by the Annenberg Center for Health Sciences at Eisenhower (ACHS) are required to disclose to the audience any real or apparent commercial financial affiliations related to the content of the presentation or enduring material. Full disclosure of all commercial relationships must be made in writing to the audience prior to the activity. Charles Willis, Director of Continuing Education, consults for Pfizer, Inc., John Bayliss, VP, Business Development, Annenberg Center, spouse is an employee of Amgen, Inc; all other staff at the Annenberg Center for Health Sciences at Eisenhower and the Chronic Liver Disease Foundation (CLDF) have no relationships to disclose.

Learner Assurance Statement

The Annenberg Center for Health Sciences at Eisenhower is committed to resolving all conflicts of interest issues that could arise as a result of prospective faculty members' significant relationships with drug or device manufacturer(s). The Annenberg Center for Health Sciences at Eisenhower is committed to retaining only those speakers with financial interests that can be reconciled with the goals and educational integrity of the CME activity.

Faculty Disclosures

Lisa Richards, MSN, FNP-BC has served on the Speaker Bureaus for AbbVie, Gilead, Intercept and Merck.

Speakers

Lisa Richards, MSN, FNP-BC

This program has expired. CME credit is no longer available.

Release Date: 12/21/2017 Expiration Date: 12/21/2018

Webcast must be viewed in its entirety to claim credit.

Accredited by:

Provided by:

Supported by:

This activity supported by an educational grant from Intercept, Merck and Salix.